Market Report
Indivior files new lawsuit over Suboxone film
Indivior has filed patent lawsuits in the USA against five rivals for infringing a patent in their respective proposed generic versions of the FTSE 250 company's Suboxone sublingual film product to treat opioid addiction.
GSK's ViiV claims Gilead Sciences infringed on its patents
ViiV Healthcare, the global specialist HIV company majority-owned by GlaxoSmithKline, with Pfizer and Shionogi as shareholders, announced on Thursday that it has filed patent infringement litigation against Gilead Sciences over bictegravir in the United States and Canada.
Bellway sees first-half revenue up 14% amid strong demand
FTSE 250 housebuilder Bellway said on Thursday that first-half housing revenue is expected to jump more than 14% amid strong demand.
AA expects full-year earnings of £390m to £395m
Roadside assistance and insurance group AA said on Thursday that full-year trading earnings before interest, tax, depreciation and amortisation are expected to come in at £390m to £395m, in line with the guidance provided in September.
Smith & Nephew profit rises as knee implant sales increase
Smith & Nephew reported a 17% rise in annual profit as the medical products company sold more knee implants and increased sales in emerging markets.
London pre-open: Stocks seen lower on Super Thursday
London stocks were set for a negative open on Thursday amid ongoing market volatility, as investors eyed the latest minutes, rate announcement and quarterly Inflation Report from the Bank of England at midday.
Thursday newspaper round-up: Brexit, Tesla, energy cap, RBS
The boss of Britain’s biggest pharmaceutical company, GlaxoSmithKline, has urged the government to sign a two-year transition deal by April to ensure the industry can cope with the impact of Brexit. Emma Walmsley, GSK’s chief executive, said the tight deadline was key to giving businesses the clarity needed to invest. “The most important thing is that we get a transition period of at least two years, starting from March 2019, but … secured by April 2018, and we need to make sure that the negotiations that are ongoing are very clearly focused on patient safety and the continued supply of medicines to patients.
US close: Markets finish red, Tesla beats on revenue and earnings
Wall Street reversed earlier gains and the previous day's recovery on Wednesday, with wary traders sending the main indices into the red, while officials at the Federal Reserve appeared to be taking a 'hands-off' approach to the recent sell-off.